Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.

about

Effect of small-dose levosimendan on mortality rates and organ functions in Chinese elderly patients with sepsis.

P2860

Q40176981-62F6791C-4E96-4D34-A082-B0E71DEE993A

P2860

Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.

Item

http://www.wikidata.org/entity/Q35994156

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@ast

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@en

type

Item

label

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@ast

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@en

prefLabel

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@ast

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@en

P1476

Levosimendan Improves Clinical ...... e in Elderly Chinese Patients.

@en

P2093

Dengqing Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Huang

http://www.w3.org/2001/XMLSchema#string

Jun Qian

http://www.w3.org/2001/XMLSchema#string

Yuanqing Yao

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan

Levosimendan: a new era for inodilator therapy for heart failure?

Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.

Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets.

Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.

Aging and heart failure: changing demographics and implications for therapy in the elderly.

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger

Mechanisms of action of calcium-sensitizing drugs.

P304

2439-2445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.893580

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281140825

http://www.w3.org/2001/XMLSchema#string

P698

26289557

http://www.w3.org/2001/XMLSchema#string

P932

4548701

http://www.w3.org/2001/XMLSchema#string

Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.

about

P2860

P2860

Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932